Yatharth Hospital & Trauma Care Services working capital

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
32.38×32.38×29.74×19.45×—
102.24×102.24×109.54×91.08×105.76×
108.23×108.23×59.59×60.96×—
26.39×26.39×79.69×49.57×—
2.53×2.29×1.14×1.51×4.84×
0.60×0.60×0.64×0.89×0.76×
1.20×1.20×1.15×−0.03×0.99×
0.70×0.70×0.68×−0.02×0.61×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

YATHARTH₹923.30

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹8,896 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)—19.4529.7432.3832.38
Receivable Days (DSO)105.7691.08109.54102.24102.24
Payable Days (DPO)—60.9659.59108.23108.23
Cash Conversion Cycle (days)—49.5779.6926.3926.39
Working Capital Turnover4.841.511.142.292.53
Asset Turnover0.760.890.640.600.60
Cash Conversion (CFO/Net Income)0.99-0.031.151.201.20
CFO/EBITDA0.61-0.020.680.700.70
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.